Solid Biosciences (SLDB) Operating Leases (2019 - 2026)
Quarterly results put Operating Leases at $18.5 million for Q1 2026, down 10.57% from a year ago — trailing twelve months through Mar 2026 was $18.5 million (down 10.57% YoY), and the annual figure for FY2025 was $19.1 million, down 9.93%.
Solid Biosciences has reported Operating Leases over the past 8 years, most recently at $18.5 million for Q1 2026.
- Operating Leases reached $18.5 million in Q1 2026 per SLDB's latest filing, down from $19.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $24.5 million in Q2 2022 and bottomed at $70000.0 in Q1 2022.
- Median Operating Leases over the past 5 years was $22.1 million (2024), compared with a mean of $20.7 million.
- The largest annual shift saw Operating Leases crashed 96.46% in 2022 before it surged 34060.0% in 2023.
- Over 5 years, Operating Leases stood at $24.3 million in 2022, then dropped by 6.47% to $22.7 million in 2023, then dropped by 6.82% to $21.2 million in 2024, then decreased by 9.93% to $19.1 million in 2025, then dropped by 3.04% to $18.5 million in 2026.
- Business Quant data shows Operating Leases for SLDB at $18.5 million in Q1 2026, $19.1 million in Q4 2025, and $19.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.48 Mn |
| Dec 31, 2025 | 19.06 Mn |
| Sep 30, 2025 | 19.62 Mn |
| Jun 30, 2025 | 20.16 Mn |
| Mar 31, 2025 | 20.66 Mn |
| Dec 31, 2024 | 21.16 Mn |
| Sep 30, 2024 | 21.64 Mn |
| Jun 30, 2024 | 22.10 Mn |
| Mar 31, 2024 | 22.53 Mn |
| Dec 31, 2023 | 22.71 Mn |
| Sep 30, 2023 | 23.19 Mn |
| Jun 30, 2023 | 23.65 Mn |
| Mar 31, 2023 | 23.91 Mn |
| Dec 31, 2022 | 24.28 Mn |
| Sep 30, 2022 | 24.27 Mn |
| Jun 30, 2022 | 24.54 Mn |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 275,000.00 |
| Sep 30, 2021 | 468,000.00 |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 2.42 Mn |
| Sep 30, 2020 | 2.94 Mn |
| Jun 30, 2020 | 3.45 Mn |
| Mar 31, 2020 | 3.94 Mn |
| Dec 31, 2019 | 4.41 Mn |
| Sep 30, 2019 | 4.87 Mn |
| Jun 30, 2019 | 5.31 Mn |
| Mar 31, 2019 | 5.74 Mn |